title: [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
authors.affiliation: Medizinische Klinik I, Städtisches Krankenhaus Solingen.
authors.forename: G
authors.initials: G
authors.lastname: Lux
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D001729:Bismuth / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005756:Gastritis / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D009853:Omeprazole / Q000008:administration & dosage*; D010437:Peptic Ulcer / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D009853:Omeprazole; D001729:Bismuth
vernacular_title: Anti-Helicobacter-pylori-Therapie. Wen, wie, wie lange behandeln?